These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 26162474)

  • 21. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods.
    Sóczó G; Kardos G; McNicholas PM; Falusi E; Gergely L; Majoros L
    Mycoses; 2007 May; 50(3):178-82. PubMed ID: 17472612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry azole susceptibility assessment in Candida and Aspergillus species.
    Giordano ALPL; Pontes L; Beraquet CAG; Lyra L; Schreiber AZ
    Mem Inst Oswaldo Cruz; 2023; 118():e220213. PubMed ID: 36921145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis.
    Marcos-Arias C; Eraso E; Madariaga L; Carrillo-Muñoz AJ; Quindós G
    Mycopathologia; 2012 Jan; 173(1):35-46. PubMed ID: 21842426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
    Minea B; Nastasa V; Moraru RF; Kolecka A; Flonta MM; Marincu I; Man A; Toma F; Lupse M; Doroftei B; Marangoci N; Pinteala M; Boekhout T; Mares M
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):367-83. PubMed ID: 25224578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric identification and antifungal susceptibility analysis of Candida species isolated from patients with invasive yeast infections in five university hospitals.
    Hu Z; Zhang J; Chen Z; Jin Z; Leng P; Zhou J; Xie X
    Braz J Microbiol; 2019 Jan; 50(1):99-105. PubMed ID: 30637643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Antifungal Susceptibility of Pathogenic Yeasts in China: A 10-Year Retrospective Study in a Teaching Hospital.
    Song Y; Chen X; Yan Y; Wan Z; Liu W; Li R
    Front Microbiol; 2020; 11():1401. PubMed ID: 32719663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata.
    Vella A; De Carolis E; Mello E; Perlin DS; Sanglard D; Sanguinetti M; Posteraro B
    Sci Rep; 2017 Aug; 7(1):9099. PubMed ID: 28831086
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Vatanshenassan M; Boekhout T; Meis JF; Berman J; Chowdhary A; Ben-Ami R; Sparbier K; Kostrzewa M
    Front Cell Infect Microbiol; 2019; 9():20. PubMed ID: 30834236
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
    Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
    J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of voriconazole against Candida species isolated in Taiwan.
    Yang YL; Cheng HH; Lo HJ
    Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species.
    Lacroix C; Gicquel A; Sendid B; Meyer J; Accoceberry I; François N; Morio F; Desoubeaux G; Chandenier J; Kauffmann-Lacroix C; Hennequin C; Guitard J; Nassif X; Bougnoux ME
    Clin Microbiol Infect; 2014 Feb; 20(2):153-8. PubMed ID: 23594150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole.
    Marinach C; Alanio A; Palous M; Kwasek S; Fekkar A; Brossas JY; Brun S; Snounou G; Hennequin C; Sanglard D; Datry A; Golmard JL; Mazier D
    Proteomics; 2009 Oct; 9(20):4627-31. PubMed ID: 19750514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism.
    Prakash A; Sharma C; Singh A; Kumar Singh P; Kumar A; Hagen F; Govender NP; Colombo AL; Meis JF; Chowdhary A
    Clin Microbiol Infect; 2016 Mar; 22(3):277.e1-9. PubMed ID: 26548511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) and Bayesian phylogenetic analysis to characterize Candida clinical isolates.
    Angeletti S; Lo Presti A; Cella E; Dicuonzo G; Crea F; Palazzotti B; Dedej E; Ciccozzi M; De Florio L
    J Microbiol Methods; 2015 Dec; 119():214-22. PubMed ID: 26551247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable isotope labelling: an approach for MALDI-TOF MS-based rapid detection of fluconazole resistance in Candida tropicalis.
    Paul S; Singh S; Chakrabarti A; Rudramurthy SM; Ghosh AK
    J Antimicrob Chemother; 2019 May; 74(5):1269-1276. PubMed ID: 30753470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11.
    Maenchantrarath C; Khumdee P; Samosornsuk S; Mungkornkaew N; Samosornsuk W
    BMC Microbiol; 2022 Jun; 22(1):153. PubMed ID: 35689195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.
    Aslani N; Janbabaei G; Abastabar M; Meis JF; Babaeian M; Khodavaisy S; Boekhout T; Badali H
    BMC Infect Dis; 2018 Jan; 18(1):24. PubMed ID: 29310582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal Susceptibility Testing of Aspergillus spp. by Using a Composite Correlation Index (CCI)-Based Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method Appears To Not Offer Benefit over Traditional Broth Microdilution Testing.
    Gitman MR; McTaggart L; Spinato J; Poopalarajah R; Lister E; Husain S; Kus JV
    J Clin Microbiol; 2017 Jul; 55(7):2030-2034. PubMed ID: 28404678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.